← back to search

Jeffrey A. Jones

Michael E. DeBakey VA Medical Center · US
Area of research
Pulmonary and Respiratory Medicine · Genetics
Research interest
Research interests include Aortic aneurysm repair treatments, Aortic Disease and Treatment Approaches, Connective tissue disorders research, and Chronic Lymphocytic Leukemia Research.
h-index
42
citations
8,535
works
239
NIH funding
primary concept
email

Recent publications

Development of a novel analysis method for evaluating PTSD-like behavior in mice based on DSM-V criteria.
2026cited by 0position: contributordoi
Smooth Muscle Cell Specific Activity of SGK-1 Alters Aortic Stiffness and Abdominal Aortic Aneurysm Growth.
2026cited by 0position: contributordoi
Thoracic Aortic Aneurysm Development Is Dependent on Membrane Type-1 Matrix Metalloproteinase Activity and Abundance.
2026cited by 0position: contributordoi
Zipalertinib in Patients With Epidermal Growth Factor Receptor Exon 20 Insertion-Positive Non–Small Cell Lung Cancer Previously Treated With Platinum-Based Chemotherapy With or Without Amivantamab
Journal of Clinical Oncology 2025cited by 9position: middledoi
Preliminary anti-leukemia activity from A phase 1 study of cln-049, a novel anti-FLT3 x anti-CD3 bispecific T-cell engager, in Relapsed/Refractory (R/R) Acute Myeloid Leukemia (AML) and myelodysplastic syndrome (MDS)
Blood 2025cited by 2position: middledoi
Femoral Vessel Occlusion Enhances Cardiac and Cerebral Perfusion in a Porcine Model of Cardiac Arrest.
2025cited by 0position: contributordoi
Safety, Tolerability, and Antitumor Activity of Zipalertinib Among Patients With Non–Small-Cell Lung Cancer Harboring Epidermal Growth Factor Receptor Exon 20 Insertions
Journal of Clinical Oncology 2023cited by 55position: middledoi
Signaling through the IL-6-STAT3 Pathway Promotes Proteolytically-Active Macrophage Accumulation Necessary for Development of Small AAA.
2023cited by 6position: contributordoi
Vascular Smooth Muscle Cell Mechanotransduction Through Serum and Glucocorticoid Inducible Kinase -1 Promotes Interleukin-6 Production and Macrophage Accumulation in Murine Hypertension
2023cited by 0position: contributordoi
Repair-Assisted Damage Detection Reveals Biological Disparities in Prostate Cancer between African Americans and European Americans
Cancers 2022cited by 17position: middledoi
Space Radiation Protection Countermeasures in Microgravity and Planetary Exploration
Life 2021cited by 71position: lastdoi
miR-133a Replacement Attenuates Thoracic Aortic Aneurysm in Mice.
2021cited by 13position: contributordoi
Blue light flexible cystoscopy with hexaminolevulinate in non-muscle-invasive bladder cancer: review of the clinical evidence and consensus statement on optimal use in the USA — update 2018
Nature Reviews Urology 2019cited by 81position: middledoi
Clinicopathological and molecular characteristics of extramedullary acute myeloid leukaemia
Histopathology 2019cited by 32position: middledoi
Elevated Wall Tension Leads to Reduced miR-133a in the Thoracic Aorta by Exosome Release.
2019cited by 15position: contributordoi
Patient‐reported outcomes of blue‐light flexible cystoscopy with hexaminolevulinate in the surveillance of bladder cancer: results from a prospective multicentre study
British Journal of Urology 2018cited by 20position: middledoi
Efficacy and Safety of Blue Light Flexible Cystoscopy with Hexaminolevulinate in the Surveillance of Bladder Cancer: A Phase III, Comparative, Multicenter Study
The Journal of Urology 2017cited by 107position: middledoi
Hsp90 inhibition increases SOCS3 transcript and regulates migration and cell death in chronic lymphocytic leukemia
Oncotarget 2016cited by 12position: middledoi
HDACs Regulate miR-133a Expression in Pressure Overload–Induced Cardiac Fibrosis
Circulation Heart Failure 2015cited by 69position: middledoi
Bisphosphonates as a supplement to exercise to protect bone during long-duration spaceflight
Osteoporosis International 2013cited by 225position: middledoi

Grants

Benign Synthesis, Bioremediation and Safer Chemical Design: Factors in P450-Substrate Interactions
NSF9996152$235,5281998–2001PIRePORTER
Benign Synthesis, Bioremediation and Safer Chemical Design: Factors in P450-Substrate Interactions
NSF9710129$206,7721997–1999PIRePORTER

Frequent collaborators

· 6 papers (2023–2026)Rupak Mukherjee · Medical University of South Carolina4 papers (2023–2026)Ashish M. Kamat · The University of Texas MD Anderson Cancer Center3 papers (2017–2019)Yair Lotan · Cancer Research Center3 papers (2017–2019)Siamak Daneshmand · The University of Texas at San Antonio3 papers (2017–2019)Kamal S. Pohar · The University of Texas Southwestern Medical Center3 papers (2017–2019)Gary D. Steinberg · Allina Health3 papers (2017–2019)Badrinath R. Konety · University of Minnesota3 papers (2017–2019)Michael Woods · National Cancer Institute3 papers (2017–2019)Sanjay Patel · Riverside Methodist Hospital3 papers (2017–2019)Trinity J. Bivalacqua · Twitter (United States)3 papers (2017–2019)Matthew J. Resnick · Vanderbilt University Medical Center3 papers (2017–2019)Jean Marie Ruddy · Medical University of South Carolina3 papers (2023–2026)Edouard J. Trabulsi · Thomas Jefferson University3 papers (2017–2019)Michael A. O’Donnell · University of Colorado Denver3 papers (2017–2019)Tracy M. Downs · University of Virginia3 papers (2017–2019)Mark Schoenberg · The Bronx Defenders2 papers (2017–2018)J. Stephen Jones · Inova Fairfax Hospital2 papers (2017–2018)Angela B. Smith · Western Sydney University2 papers (2018–2019)Joel DeCastro · NewYork–Presbyterian Hospital2 papers (2017–2018)